Primitive neuroectodermal tumor: Difference between revisions
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} PNET; Askin tumor; peripheral neuroepithelioma | {{SK}} PNET; Askin tumor; peripheral neuroepithelioma; ependymoblastoma | ||
== Overview == | == Overview == | ||
'''Primitive Neuroectodermal Tumors''', or '''PNET''', refers to two different tumor types. These include Peripheral PNET and CNS PNET. This can be a source of confusion. | '''Primitive Neuroectodermal Tumors''', or '''PNET''', refers to two different tumor types. These include Peripheral PNET and CNS PNET. This can be a source of confusion. | ||
==Ependymoblastoma | <ref>[http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&diseaseID=9323 Ependymoblastoma] at US National Institutes of Health Office of Rare Diseases</ref> | ||
==Classification== | |||
===Peripheral PNET=== | ===Peripheral PNET=== | ||
| Line 45: | Line 43: | ||
Using gene transfer of SV40 large T-antigen in neuronal precursor cells of rats, a brain tumor model was established. The PNETs were histologically indistinguishable from the human counterparts and have been used to identify new genes involved in human brain tumor carcinogenesis. <ref>Eibl RH, Kleihues P, Jat PS, Wiestler OD (1994) A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen. Am J Pathol. 1994 Mar;144(3):556-64.</ref>. The model was used to confirm p53 as one of the genes involved in human medulloblastomas, but since only about 10 % of the human tumors showed mutations in that gene, the model can be used to identify the other binding partners of SV40 Large T- antigen, other than p53. <ref>Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P: p53 mutations in nonastrocytic human brain tumors. Cancer Res (1991) 51:6202-5</ref> | Using gene transfer of SV40 large T-antigen in neuronal precursor cells of rats, a brain tumor model was established. The PNETs were histologically indistinguishable from the human counterparts and have been used to identify new genes involved in human brain tumor carcinogenesis. <ref>Eibl RH, Kleihues P, Jat PS, Wiestler OD (1994) A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen. Am J Pathol. 1994 Mar;144(3):556-64.</ref>. The model was used to confirm p53 as one of the genes involved in human medulloblastomas, but since only about 10 % of the human tumors showed mutations in that gene, the model can be used to identify the other binding partners of SV40 Large T- antigen, other than p53. <ref>Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P: p53 mutations in nonastrocytic human brain tumors. Cancer Res (1991) 51:6202-5</ref> | ||
== | ==Related Chapters== | ||
*[[Ependymoma]] | *[[Ependymoma]] | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
== Acknowledgements == | == Acknowledgements == | ||
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D. | The content on this page was first contributed by: C. Michael Gibson, M.S., M.D. | ||
[[de:Primitiv neuroektodermaler Tumor]] | [[de:Primitiv neuroektodermaler Tumor]] | ||
[[pl:Obwodowy niedojrzały guz neuroektodermalny]] | [[pl:Obwodowy niedojrzały guz neuroektodermalny]] | ||
Revision as of 12:56, 17 September 2012
| Primitive neuroectodermal tumor | |
| ICD-O: | M9473/3 |
|---|---|
| DiseasesDB | 31470 |
| MeSH | D018242 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: PNET; Askin tumor; peripheral neuroepithelioma; ependymoblastoma
Overview
Primitive Neuroectodermal Tumors, or PNET, refers to two different tumor types. These include Peripheral PNET and CNS PNET. This can be a source of confusion.
Classification
Peripheral PNET
The Peripheral PNET is now thought to be virually identical to Ewing sarcoma:
"Current evidence indicates that both Ewing's sarcoma and PNET have a similar neural phenotype and, because they share an identical chromosome translocation, they should be viewed as the same tumor, differing only in their degree of neural differentiation. Tumors that demonstrate neural differentiation by light microscopy, immunohistochemistry, or electron microscopy have been traditionally labeled PNETs, and those that are undifferentiated by these analyses have been diagnosed as Ewing's sarcoma." [2]
PNET of the CNS
PNET of the CNS are grossly divided into supratentorial PNET and infratentorial PNET, the latter being more common. [3]
An example of infratentorial PNET includes Medulloblastomas, which occurs in the cerebellum.
An example of supratentorial PNET includes Pinealoblastomas, which occurs in the pineal region.
Model
Using gene transfer of SV40 large T-antigen in neuronal precursor cells of rats, a brain tumor model was established. The PNETs were histologically indistinguishable from the human counterparts and have been used to identify new genes involved in human brain tumor carcinogenesis. [4]. The model was used to confirm p53 as one of the genes involved in human medulloblastomas, but since only about 10 % of the human tumors showed mutations in that gene, the model can be used to identify the other binding partners of SV40 Large T- antigen, other than p53. [5]
Related Chapters
References
- ↑ Ependymoblastoma at US National Institutes of Health Office of Rare Diseases
- ↑ Robbins Pathologic Basis of Disease, 7th edition
- ↑ Subrata Ghosh, MD, MBBS, MS, Primitive Neuroectodermal Tumors of the Central Nervous System, eMedicine 2007.
- ↑ Eibl RH, Kleihues P, Jat PS, Wiestler OD (1994) A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen. Am J Pathol. 1994 Mar;144(3):556-64.
- ↑ Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P: p53 mutations in nonastrocytic human brain tumors. Cancer Res (1991) 51:6202-5
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.